Close Menu

Caprotec Bioanalytics

While chemical proteomics has traditionally focused on pharmaceutical work, several recent collaborations suggest that the field is establishing a foothold within agricultural research, as well.

NEW YORK (GenomeWeb News) – Berlin-based biotech-firm Caprotec Bioanalytics said today that it has entered a research agreement with Syngenta to profile the interactions of one of Syngenta's active compounds with the proteome of certain relevant plant systems.

NEW YORK (GenomeWeb News) – Berlin-based biotech-firm Caprotec Bioanalytics said today that it has entered a research collaboration with Bayer CropScience to identify and study an agrochemical target.

BG Medicine has appointed Charles Abdalian to be executive VP and chief financial officer. Mike Rogers will be departing the company after three-and-a-half years as CFO.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Caprotec Bioanalytics has reached an agreement to use its technology to screen an undisclosed new active ingredient from Bayer CropScience.

Movers & Shakers: Sep 16, 2011

Premium

Olink Bioscience this week appointed Simon Fredriksson as its new president and CEO, replacing Bjorn Ekstrom, who has led the company since its founding in 2004 and will be joining its board of directors.

Movers & Shakers: Jul 15, 2011

Premium

Marc Voigt, Lars Rebien Sorensen, Robert McBurney

Movers & Shakers: May 13, 2011

Premium

Arthur Moseley, David Lemus, Rainer Metternich, William Curry

This round of financing will allow the company to move into new markets and pursue partnerships with pharmaceutical firms.

Movers & Shakers: Oct 8, 2010

Premium

Gregory Critchfield, Ian Pike, Rainer Metternich

Pages

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.